3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Leukemia, Myeloid, Acute
124
Myelodysplastic Syndromes
119
Precursor Cell Lymphoblastic Leukemia-Lymphoma
106
Leukemia
85
Hodgkin Disease
80
Leukemia, Lymphocytic, Chronic, B-Cell
77
Lymphoma
75
Multiple Myeloma
74
Lymphoma, Non-Hodgkin
74
Myeloproliferative Disorders
57
Graft vs Host Disease
55
Lymphoma, Follicular
53
Lymphoma, Mantle-Cell
49
Lymphoma, Large B-Cell, Diffuse
49
Leukemia, Myeloid, Accelerated Phase
49
Leukemia, Myelomonocytic, Chronic
48
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
47
Congenital Abnormalities
47
Hematologic Neoplasms
45
Leukemia, Myeloid, Chronic-Phase
44
Lymphoma, B-Cell, Marginal Zone
43
Primary Myelofibrosis
41
Burkitt Lymphoma
41
Blast Crisis
38
Neoplasms, Plasma Cell
37
Lymphoma, Large-Cell, Immunoblastic
33
Waldenstrom Macroglobulinemia
25
Myelodysplastic-Myeloproliferative Diseases
25
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
25
Anemia, Refractory, with Excess of Blasts
24
Interventions
apixaban
18
Dalteparin
15
Rivaroxaban
11
Enoxaparin
10
Heparin, Low-Molecular-Weight
8
Aspirin
8
Tinzaparin
7
Warfarin
3
Fondaparinux
3
edoxaban
2
bemiparin
2
abelacimab
2
Rosuvastatin Calcium
2
Nadroparin
2
MAA868
2
Dabigatran
2
sotorasib
1
reviparin
1
isoquercitrin
1
enoxaparin sodium
1
certoparin
1
betrixaban
1
argatroban
1
acarboxyprothrombin
1
Tacrolimus
1
Tablets
1
Simvastatin
1
Platelet Transfusion
1
Phenprocoumon
1
Observation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Venous Thromboembolism
×
Tacrolimus
×
Clear all
NCT03083782
2017-10-11
ACT
Thomas Jefferson University
Phase 1
Completed
12 enrolled